A splicing isoform of LPP1, LPP1a, exhibits high phosphatase activity toward FTY720 phosphate

Biochemical and Biophysical Research Communications

Volumn 375, Issue 4, 2008, Pages 675-679

  Yamanaka, Masao ^a   Anada, Yoshihiro ^a   Igarashi, Yasuyuki ^a   Kihara, Akio ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Endothelial cell; FTY720; Immunomodulating agent; LPP; Plasma; Sphingosine 1 phosphate

Indexed keywords

ENZYME; FINGOLIMOD; LIPID PHOSPHATASE 1 ENZYME; LIPID PHOSPHATASE 1A ENZYME; LIPID PHOSPHATASE 2 ENZYME; LIPID PHOSPHATASE 3 ENZYME; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ALTERNATIVE SPLICING; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ENDOTHELIAL CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHOSPHATIDATE PHOSPHATASE; PROPYLENE GLYCOLS; PROTEIN ISOFORMS; SPHINGOSINE;

EID: 51449085114     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.165     Document Type: Article

References (23)

1. Kihara A., Mitsutake S., Mizutani Y., and Igarashi Y. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Prog. Lipid Res. 46 (2007) 126-144
2. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., Liu C.H., Hla T., Spiegel S., and Proia R.L. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106 (2000) 951-961
3. Mizugishi K., Yamashita T., Olivera A., Miller G.F., Spiegel S., and Proia R.L. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25 (2005) 11113-11121
4. Chiba K., Matsuyuki H., Maeda Y., and Sugahara K. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. Cell. Mol. Immunol. 3 (2006) 11-19
5. Budde K., Schütz M., Glander P., Peters H., Waiser J., Liefeldt L., Neumayer H.H., and Böhler T. FTY720 (fingolimod) in renal transplantation. Clin. Transplant. 20 Suppl. 17 (2006) 17-24
6. Mandala S., Hajdu R., Bergstrom J., Quackenbush E., Xie J., Milligan J., Thornton R., Shei G.J., Card D., Keohane C., Rosenbach M., Hale J., Lynch C.L., Rupprecht K., Parsons W., and Rosen H. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296 (2002) 346-349
7. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., Bruns C., Prieschl E., Baumruker T., Hiestand P., Foster C.A., Zollinger M., and Lynch K.R. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277 (2002) 21453-21457
8. Zhou J., and Saba J.D. Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biochem. Biophys. Res. Commun. 242 (1998) 502-507
9. Mandala S.M., Thornton R., Galve-Roperh I., Poulton S., Peterson C., Olivera A., Bergstrom J., Kurtz M.B., and Spiegel S. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death. Proc. Natl. Acad. Sci. USA 97 (2000) 7859-7864
10. Ogawa C., Kihara A., Gokoh M., and Igarashi Y. Identification and characterization of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2. J. Biol. Chem. 278 (2003) 1268-1272
11. Ikeda M., Kihara A., and Igarashi Y. Sphingosine-1-phosphate lyase SPL is an endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5′-phosphate binding domain exposed to the cytosol. Biochem. Biophys. Res. Commun. 325 (2004) 338-343
12. Pyne S., Long J.S., Ktistakis N.T., and Pyne N.J. Lipid phosphate phosphatases and lipid phosphate signalling. Biochem. Soc. Trans. 33 (2005) 1370-1374
13. Sigal Y.J., McDermott M.I., and Morris A.J. Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions. Biochem. J. 387 (2005) 281-293
14. Billich A., Bornancin F., Devay P., Mechtcheriakova D., Urtz N., and Baumruker T. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278 (2003) 47408-47415
15. Kharel Y., Lee S., Snyder A.H., Sheasley-O'neill S L., Morris M.A., Setiady Y., Zhu R., Zigler M.A., Burcin T.L., Ley K., Tung K.S., Engelhard V.H., Macdonald T.L., Pearson-White S., and Lynch K.R. Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J. Biol. Chem. 280 (2005) 36865-36872
16. Ito K., Anada Y., Tani M., Ikeda M., Sano T., Kihara A., and Igarashi Y. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem. Biophys. Res. Commun. 357 (2007) 212-217
17. Yatomi Y. Plasma sphingosine 1-phosphate metabolism and analysis. Biochim. Biophys. Acta 1780 (2008) 606-611
18. Anada Y., Igarashi Y., and Kihara A. The immunomodulator FTY720 is phosphorylated and released from platelets. Eur. J. Pharmacol. 568 (2007) 106-111
19. Bandhuvula P., Tam Y.Y., Oskouian B., and Saba J.D. The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity. J. Biol. Chem. 280 (2005) 33697-33700
20. Mechtcheriakova D., Wlachos A., Sobanov J., Bornancin F., Zlabinger G., Baumruker T., and Billich A. FTY720-phosphate is dephosphorylated by lipid phosphate phosphatase 3. FEBS Lett. 581 (2007) 3063-3068
21. Kihara A., Ikeda M., Kariya Y., Lee E.Y., Lee Y.M., and Igarashi Y. Sphingosine-1-phosphate lyase is involved in the differentiation of F9 embryonal carcinoma cells to primitive endoderm. J. Biol. Chem. 278 (2003) 14578-14585
22. Leung D.W., Tompkins C.K., and White T. Molecular cloning of two alternatively spliced forms of human phosphatidic acid phosphatase cDNAs that are differentially expressed in normal and tumor cells. DNA Cell Biol. 17 (1998) 377-385
23. Nanjundan M., and Possmayer F. Molecular cloning and expression of pulmonary lipid phosphate phosphohydrolases. Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L1484-L1493